Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Narayana Hrudayalaya Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹28,440 Mn (+73% YoY), EBITDA ₹6,054 Mn (21.3% margin), PAT ₹3,012 Mn (10.6% margin). Growth from capacity expansion and UK consolidation.

Highlights
Revenue growth+73% YoY, +6% QoQ; UK not in prior-year base
MarginsIndia hospitals 26.8% vs 23.8% YoY; consolidated 21.3%
Demand visibilityBengaluru discharges +7%; Southern peripheral +1% YoY

Growth

Revenue +73% YoY, +6% QoQ; EBITDA +42% YoY; PAT +16.6% YoY. NH India revenue +16.6%, HCCI +28.2% YoY.

Outlook

FY27 capex actual ₹1,636 Mn vs ₹7,300 Mn planned; bed capacity target 7,800+ by FY30. No numeric revenue guidance.

Risks

Insurance PAT loss ₹151 Mn, combined ratio 282%. UK EBITDA down 18.5% QoQ; PAT margin 10.6% vs 15.7%.

Last quarter's promises, checked

Delivered

  • Guided core margin expansion (unquantified) → India hospitals 26.8% vs 23.8% YoY (= BEAT)

Partly delivered

  • Guided SW Bangalore 100 beds start by end-Q2 → Banashankari commenced late Sep'26; link unconfirmed (= PARTIAL)
  • Guided 2 clinics in Q2 → Nagarabhavi clinic commenced, 1 of 2 confirmed (= PARTIAL)

Missed

  • Guided ₹30,000 Mn capex over 2 yrs → FY27 capex ₹1,636 Mn vs ₹7,300 Mn plan, 22% (= MISS)
Source

Investor Presentation filed with BSE, NSE: NH. Summary written with AI assistance from the document.

Read the document ↗

Narayana Hrudayalaya Ltd: key numbers

Share price
₹1,720.20
Market cap
₹35,154 Cr
Revenue (annual)
₹7,896 Cr
Net profit (annual)
₹805.6 Cr
P/E (TTM)
43.1×Sector 52.3×
Promoter holding
63.27%+0.00% QoQ
FII holding
9.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Narayana Hrudayalaya Ltd

All →